Quality assessment of pharmacoeconomic abstracts of original research articles in selected journals

Annals of Pharmacotherapy

Volumn 31, Issue 4, 1997, Pages 423-428

  Trakas, Kostas ^a   Addis, Antonio ^b,c   Kruk, Dorothy ^d   Buczek, Yvona ^a   Iskedjian, Michael ^d   Einarson, Thomas R ^b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

abstracts; literature analysis; pharmacoeconomics; quality

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DRUG COST; DRUG RESEARCH; HEALTH ECONOMICS; MEDICAL LITERATURE; MEDICAL RESEARCH; PHARMACY; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL;

EID: 0030900301     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100406     Document Type: Article

References (12)

1. Bradley CA, Iskedjian M, Lanctôt KL, Mittmann N, Simone C, St Pierre E, et al. Quality assessment of economic evaluations in selected pharmacy, medical, and health economics journals. Ann Pharmacother 1995;29:681-6.
2. Elixhauser A, Luce B, Taylor W, Reblando J. Health care CBA/CEA: an update on the growth and composition of the literature. Med Care 1993;31(suppl 7):JS1-JS11.
3. Ad Hoc Working Group for Critical Appraisal of the Medical Literature. A proposal for more informative abstracts of clinical articles. Ann Intern Med 1987;107:790-1.
4. Taddio A, Pain T, Fassos F, Boon H, Ilersich AL, Einarson TR. Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal, and the Journal of the American Medical Association. Can Med Assoc J 1994;150:1611-5.
5. Lee J, Sanchez L. Interpretation of "cost-effective" and soundness of economic evaluations in the pharmacy literature. Am J Hosp Pharm 1991;48:2622-7.
6. Ontario guidelines for economic analysis of pharmaceutical products. Toronto: Ministry of Health (Government of Ontario), 1995.
7. Jacobs P, Bachynsky J, Baladi JF. A comparative review of pharmacoeconomic guidelines. PharmacoEconomics 1995;8:182-9.
8. Drummond N, Stoddart M, Torrance G. Integrated care for asthma: a clinical, social, and economic evaluation. BMJ 1994;308:559-64.
9. Sanchez L. Evaluating the quality of published pharmacoeconomic evaluations. Hosp Pharm 1995;30:146-8,151-2.
10. Doubilet P, Weinstein M, McNeil B, Epstein A. The use and misuse of the term "cost effective" in medicine. N Engl J Med 1986;314:253-6.
11. Udvarhelyi S, Colditz G, Rai A. Cost effectiveness and cost benefit analyses in the medical literature. Ann Intern Med 1992;116:238-44.
12. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press, 1969.